Jonathan Rosenberg, MD
Memorial Sloan Kettering Cancer Center
2
2
1
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Andrea B Apolo, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Ahmed Mosbah, MD
Urology and nephrology center
Shared therapeutic areas:
Mark Lanasa, MD
One MedImmune Way,Gaithersburg,Maryland,United States
Shared therapeutic areas:
Worked with same sponsors:
Lizhi Niu, PhD
Fuda Cancer Hospital
Shared therapeutic areas:
Lung-Ji Chang, PhD
Shenzhen Geno-Immune Medical Institute
Shared therapeutic areas:
Jitendra Amlani, MD
Urocare Hospital
Shared therapeutic areas:
Gustavo Leone
Medical University of South Carolina, Hollings Cancer Center
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Sushil Bhatia, MD
Choithram Hospital and Research Centre
Shared therapeutic areas:
Yoshiya Yamada, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
All 2 trials loaded